↓ Skip to main content

Prognostic and predictive value of NanoString-based immune-related gene signatures in a neoadjuvant setting of triple-negative breast cancer: relationship to tumor-infiltrating lymphocytes

Overview of attention for article published in Breast Cancer Research and Treatment, May 2015
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
56 Dimensions

Readers on

mendeley
96 Mendeley
citeulike
1 CiteULike
Title
Prognostic and predictive value of NanoString-based immune-related gene signatures in a neoadjuvant setting of triple-negative breast cancer: relationship to tumor-infiltrating lymphocytes
Published in
Breast Cancer Research and Treatment, May 2015
DOI 10.1007/s10549-015-3438-8
Pubmed ID
Authors

Hee Jin Lee, Jeong-Ju Lee, In Hye Song, In Ah Park, Jun Kang, Jong Han Yu, Jin-Hee Ahn, Gyungyub Gong

Abstract

The prognostic significance of tumor-infiltrating lymphocytes and immune signals has been described previously in triple-negative breast cancer (TNBC). Furthermore, recent studies have shown that immunologic parameters are relevant for the response to neoadjuvant chemotherapy (NAC) in breast cancer as well as for outcomes after adjuvant chemotherapy. However, immune signals are variable, and which signals are important is largely unknown. We, therefore, evaluated the expression of immune-related genes in TNBC treated with NAC. We retrospectively evaluated biopsy tissue from 55 patients with primary TNBC treated with NAC (anthracycline, cyclophosphamide, and docetaxel) against the NanoString nCounter GX Human Immunology Panel (579 immune-related genes). Higher expression of cytotoxic molecules, T cell receptor signaling pathway components, cytokines related to T helper cell type 1 (Th1), and B cell markers was associated with a pathologic complete response (pCR). Higher expression of NFKB1, MAPK1, TRAF1, CXCL13, GZMK, and IL7R was significantly associated with pCR, higher Miller-Payne grade, and lower residual cancer burden class. Expression of NFKB1, TRAF1, and CXCL13genes, in particular, was significantly correlated with a longer disease-free survival rate. Conversely, patients those who failed to achieve a pCR showed increased expression of genes related to neutrophils. Higher expression of cytotoxic molecules, T cell receptor signaling pathway components, Th1-related cytokines, and B cell markers is correlated with pCR and survival in TNBC patients treated with NAC. Our results suggest that the activation status of neutrophils may provide additional predictive information for TNBC patients treated with NAC.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
Spain 1 1%
Netherlands 1 1%
Unknown 93 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 19 20%
Student > Ph. D. Student 15 16%
Student > Master 10 10%
Student > Bachelor 7 7%
Student > Postgraduate 5 5%
Other 15 16%
Unknown 25 26%
Readers by discipline Count As %
Medicine and Dentistry 25 26%
Agricultural and Biological Sciences 14 15%
Biochemistry, Genetics and Molecular Biology 10 10%
Immunology and Microbiology 4 4%
Nursing and Health Professions 2 2%
Other 7 7%
Unknown 34 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 February 2016.
All research outputs
#19,015,492
of 23,577,654 outputs
Outputs from Breast Cancer Research and Treatment
#3,776
of 4,738 outputs
Outputs of similar age
#194,416
of 267,916 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#54
of 72 outputs
Altmetric has tracked 23,577,654 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,738 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one is in the 12th percentile – i.e., 12% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 267,916 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 72 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.